Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...

The European Medicines Agency (EMA) has recommended extending the use of Mounjaro to younger patients with diabetes, ...

The new CalRx insulin will hit the market in January at $55 a month, part of a broader state effort to rein in drug costs.

Groundbreaking Harvard research reveals gut-produced molecules significantly influence obesity and blood sugar control. These ...

The Medicines and Healthcare products Regulatory Agency (MHRA) highlighted the example of warfarin, a drug commonly used to ...

Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years.